Saturday 12 October 2024
DAILY NEWS
Issue 3
The official newspaper of the 38th EACTS Annual Meeting 2024 ANNUAL MEETING
Highlights from Friday at the 38th EACTS Annual Meeting.
3 GENERAL ASSEMBLY
We welcome Volkmar Falk as the new EACTS President. Find out more about the Officers and Councillors elected during yesterday evening's EACTS General Assembly.
5 ALLIED HEALTH PROFESSIONALS COMMITTEE
The importance of the patient's voice in delivering high quality care is just one of the topics discussed in today's allied health professionals committee sessions.
11
Senator Guisy Versace shared her story with delegates to highlight the importance of positivity, one of Franca Melfi's three principles in her Presidential Address.
DIVING INTO THE DATA
Bart Scheenstra presents the paper 'Personalised multimodal teleprehabilitation in elective cardiac surgery’
Today’s ‘Trial Update Session’ will be a valuable opportunity to learn more about some important current trials that could impact clinical practice and guidelines in the future. A highlight of this year’s scientific programme, this focus session will cover three main areas: surgical mitral valve repair versus transcatheter edge-to-edge repair (TEER), treatments for aortic stenosis and myocardial revascularisation. Presenters will delve deep into the data, discussing the details behind the trials and what the results could mean for patient care. Patrick Myers, Secretary General, said, “This session is invaluable for EACTS members. This is our opportunity to learn about the latest trials and familiarise ourselves with aspects of trial design. The way in which trials are established is critical and I am keen that as surgeons we contribute our skills and experience to improve trial design in the future. This session is a forum to discuss the results of trials and will give us key insights so that we can have informed discussions within our heart teams.’
TODAY AT THE ANNUAL MEETING
Joanna Chikwe, the primary investigator of one of two major mitral valve repairs trials, will present on the ‘Current trends and future perspectives of Surgical Repair and TEER for the treatment of primary mitral regurgitation’. Current data shows the main benefits of TEER are in patients with secondary mitral regurgitation. Patients in Europe with primary regurgitation are currently treated surgically, with excellent results. In the US, TEER is used more widely to treat both primary and secondary regurgitation. This current trial may change things. If the data shows that TEER can be used effectively for patients with primary regurgitation, European guidance may change. Joanna Chikwe will present an overview of what the trials are investigating, how they have been designed and the expected outcomes. Current trials focused on aortic stenosis and the benefits of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) in treating aortic valves will also be discussed. Torsten Doenst, Chairman of the Department of Cardiothoracic Surgery at the University of Jena, Germany, will explore the long-term outcomes in TAVI and SAVR. While TAVI achieves very positive short-term results in selected patients, Torsten Doenst will give an overview of current trial data looking at the longer-term outcomes of TAVI. Continued on page 2
Keynote Lecture
Awards Ceremony
Roberto Canessa will share his story of survival and how it has inspired his remarkable life.
Celebrate training and research excellence at this year's Annual Meeting.
12:35 - 13:20
12:35 - 13:20
Auditorium 1
Auditorium 1